Advancements in COPD treatment are offering relief to thousands of Kentuckians by targeting inflammation directly without the ...

The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales ...

Jorgen Vestbo, MD, on the COPERNICOS trial results, long-term antibiotic use versus resistance concerns, and where COPD treatment is headed. The COPERNICOS (NCT04481555) trial, a multicenter, ...

An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market ...

AstraZeneca’s experimental COPD drug has significantly reduced flare-ups in two late-stage trials, making FDA approval in ...

A new drug shows promise in reducing the symptoms of COPD, one of the top 10 leading cause of death in the U.S., according to ...

Persistent access barriers leave many treatment candidates without advanced therapy as physicians look for stronger disease ...

COPD is the third leading cause of death worldwide, excluding COVID-19. It is a progressive respiratory condition ...

AstraZeneca's experimental drug, tozorakimab, significantly reduces COPD exacerbations, as presented at the European Respiratory Society Congress. The drug, effective regardless of smoking status or ...

Add Yahoo as a preferred source to see more of our stories on Google. Jul. 1—MORGANTOWN — A new treatment for emphysema is coming to West Virginia. The Zephyr Valve, a treatment classified a medical ...

A small trial found that laughter therapy and pursed-lip breathing reduced reported breathlessness in people with COPD.

The goals of COPD treatment are to reduce symptoms and symptom flare-ups. "This can be done through a combination of lifestyle changes and treatment options in consultation with your doctor," says ...